報價延遲最少15分鐘:2025/07/03 06:17 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
157.49 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.61/9.83
|
|
企業價值
10.31B
|
| 資產負債 |
|
每股賬面淨值
65.04
|
| 現金流量 |
|
現金流量率
0.10
|
| 損益表 |
|
收益
4.05B
|
|
每股收益
85.83
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/03 06:17 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services. |